Trial intelligence / Profile preview

Comparison of single-dose methotrexate versus actinomycin D to prevent gestational trophoblastic neoplasia in high-risk hydatidiform mole

IRCT20130311012782N40Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in trophoblastic tumour and hydatidiform mole (HM) comparing Single-dose methotrexate prophylaxis with Single-dose actinomycin D prophylaxis (2 arms). Started Apr 2020; status: completed.

02

Drugs

methotrexateactinomycin D
03

Conditions

trophoblastic tumourhydatidiform mole (HM)

Beyond the preview

Go deeper on IRCT20130311012782N40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130311012782N40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call